NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
Company Presentation
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma Information | NMD Pharma Profile
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma - PIR International
NMD Pharma - Inkef capital
Erhverv Aarhus - 照片| Facebook
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
Investors — NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis | MENAFN.COM
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
Prominent Canadian researcher in Denmark: Why I left a top job in California
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
Management — NMD Pharma
NMD Pharma — NMD Pharma
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
NMD Pharma - Capnova
NMD | LinkedIn
